Wasatch Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Sell
312,767
-391
-0.1% -$12.6K 0.08% 134
2026
Q1
$10.2M Buy
313,158
+147,752
+89% +$4.75M 0.07% 126
2025
Q4
$5.82M Buy
165,406
+36,939
+29% +$1.31M 0.03% 171
2025
Q3
$3.38M Sell
128,467
-133,578
-51% -$3.99M 0.02% 204
2025
Q2
$6.94M Buy
262,045
+4,597
+2% +$121K 0.04% 172
2025
Q1
$6.22M Buy
257,448
+76,530
+42% +$2.42M 0.03% 175
2024
Q4
$7.28M Sell
180,918
-46,802
-21% -$2.67M 0.04% 176
2024
Q3
$14.4M Sell
227,720
-25,449
-10% -$1.49M 0.07% 138
2024
Q2
$13.4M Sell
253,169
-2,367
-0.9% -$155K 0.07% 142
2024
Q1
$21M Sell
255,536
-1,019,409
-80% -$45.4M 0.11% 132
2023
Q4
$23.7M Buy
1,274,945
+311,681
+32% +$4.08M 0.13% 120
2023
Q3
$10.7M Sell
963,264
-746,211
-44% -$10.7M 0.07% 143
2023
Q2
$27.7M Buy
1,709,475
+4,031
+0.2% +$84.5K 0.17% 106
2023
Q1
$28.4M Buy
+1,705,444
New +$17.6M 0.18% 106

Other funds holding VKTX